scholarly article | Q13442814 |
P819 | ADS bibcode | 1996PNAS...9314928M |
P356 | DOI | 10.1073/PNAS.93.25.14928 |
P932 | PMC publication ID | 26239 |
P698 | PubMed publication ID | 8962158 |
P5875 | ResearchGate publication ID | 14245921 |
P50 | author | Rosario Moratalla | Q38329789 |
P2093 | author name string | M Xu | |
A M Graybiel | |||
S Tonegawa | |||
P2860 | cites work | Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter | Q24310836 |
Expression and pharmacological characterization of the human D3 dopamine receptor | Q24337093 | ||
Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum | Q24557423 | ||
Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity | Q28369508 | ||
Altered striatal function in a mutant mouse lacking D1A dopamine receptors | Q28585357 | ||
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses | Q28585702 | ||
Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors | Q28587334 | ||
Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice | Q28591400 | ||
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments | Q34320761 | ||
Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain | Q34327236 | ||
Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism | Q34417053 | ||
Neurotransmitters and neuromodulators in the basal ganglia | Q36586002 | ||
Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated | Q36599964 | ||
Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors | Q37400861 | ||
Sequence and expression of the rat prodynorphin gene | Q37692494 | ||
Multiple receptors for dopamine | Q37876912 | ||
Are neostriatal dopamine receptors co-localized? | Q40490180 | ||
Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system | Q40546869 | ||
Recent advances in the molecular biology of dopamine receptors | Q40890829 | ||
Striatal interneurones: chemical, physiological and morphological characterization | Q40991491 | ||
Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum | Q41922304 | ||
Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum | Q42453575 | ||
Amphetamine- and cocaine-induced fos in the rat striatum depends on D2 dopamine receptor activation | Q42489105 | ||
D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects | Q42506008 | ||
Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal | Q42521545 | ||
D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons | Q44243782 | ||
The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors | Q44319553 | ||
Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum | Q46299867 | ||
Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum | Q48221326 | ||
Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine | Q48339954 | ||
Distribution of cocaine recognition sites in monkey brain: I. In vitro autoradiography with [3H]CFT | Q48631460 | ||
Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum | Q48892221 | ||
Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation | Q48947498 | ||
Induction of c-fos mRNA Expression in Rat Striatum by Neuroleptic Drugs | Q49050223 | ||
Medial Dorsal Striatum Is More Sensitive Than Lateral Dorsal Striatum to Cocaine Inhibition of Exogenous Dopamine Clearance: Relation to [3H]Mazindol Binding, but Not Striosome/Matrix | Q51599557 | ||
Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs | Q51607834 | ||
Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. | Q51609461 | ||
Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. | Q51626410 | ||
Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. | Q51654607 | ||
D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. | Q52012047 | ||
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. | Q52051956 | ||
Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens | Q72675800 | ||
P433 | issue | 25 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
P304 | page(s) | 14928-14933 | |
P577 | publication date | 1996-12-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor | |
P478 | volume | 93 |
Q28591330 | Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine |
Q46937750 | Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice |
Q28142501 | Addiction, dopamine, and the molecular mechanisms of memory |
Q22251215 | Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants |
Q30490216 | Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior |
Q46488765 | Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice |
Q42906391 | Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null, Drd1a-/- mice and in hippocampal siRNA silenced Drd1a mice. |
Q34139483 | Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. |
Q37351631 | Augmented D1 dopamine receptor signaling and immediate-early gene induction in adult striatum after prenatal cocaine |
Q40860075 | Behavior in mice with targeted disruption of single genes |
Q48189119 | Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function |
Q44394157 | Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors |
Q41679403 | Brain regions and monoaminergic neurotransmitters that are involved in mouse ambulatory activity promoted by bupropion |
Q52299778 | CREB involvement in the regulation of striatal prodynorphin by nicotine. |
Q37107267 | CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat. |
Q38342952 | Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. |
Q32062397 | Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat. |
Q44259228 | Congenic D1A dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype. |
Q28138148 | Coupling of dopamine receptor subtypes to multiple and diverse G proteins |
Q40227540 | D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice |
Q48223824 | D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus |
Q48550675 | D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja |
Q48101097 | Decreased c-fos responses to dopamine D(1) receptor agonist stimulation in mice deficient for D(3) receptors |
Q43734938 | Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. |
Q42525075 | Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease |
Q34881236 | Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats |
Q44003283 | Differential rat brain expression of EGR proteins and of the transcriptional corepressor NAB in response to acute or chronic cocaine administration |
Q43456187 | Differential regulation of immediate-early gene expression in the prefrontal cortex of rats with a high vs low behavioral response to methamphetamine |
Q28185479 | Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity |
Q36241219 | Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? |
Q34372135 | Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling |
Q34386011 | Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs |
Q48229048 | Dopamine depresses glutamatergic synaptic transmission in the rat parabrachial nucleus in vitro |
Q34438043 | Dopamine receptor functions: lessons from knockout mice [corrected]. |
Q48280361 | Dopaminergic regulation of olfactory type G-protein α subunit expression in the striatum |
Q43070951 | Drugs of abuse and immediate-early genes in the forebrain |
Q48158941 | Early bi-parental separation or neonatal paternal deprivation in mandarin voles reduces adult offspring paternal behavior and alters serum corticosterone levels and neurochemistry |
Q44341189 | Early modulation by the dopamine D4 receptor of morphine-induced changes in the opioid peptide systems in the rat caudate putamen |
Q37054169 | Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice |
Q44374188 | Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine |
Q60800983 | Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress |
Q34970664 | Experimental genetic approaches to addiction. |
Q42814848 | Exploring mechanisms underlying extinction of cue-elicited cocaine seeking |
Q42520647 | Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. |
Q44511949 | Firing regulation in dopaminergic cells: effect of the partial degeneration of nigrostriatal system in surviving neurons |
Q37021177 | Fos regulates neuronal activity in the nucleus accumbens |
Q38340269 | G protein-coupled receptors: functional and mechanistic insights through altered gene expression |
Q46815350 | Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine |
Q48438578 | Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts |
Q77147080 | Genetics of alcohol and other abused drugs |
Q36651107 | Hypothalamic neural circuits regulating maternal responsiveness toward infants |
Q22255498 | Imaging Cerebral Gene Transcripts in Live Animals |
Q44407165 | Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization |
Q51409749 | Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons. |
Q51423988 | Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. |
Q73676240 | L-prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum |
Q48443202 | Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice |
Q37330735 | Medial preoptic area interactions with dopamine neural systems in the control of the onset and maintenance of maternal behavior in rats |
Q41860851 | Methamphetamine and Parkinson's disease |
Q34669781 | Molecular dissection of dopamine receptor signaling. |
Q42528574 | Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype |
Q34589454 | Motor-skill learning in a novel running-wheel task is dependent on D1 dopamine receptors in the striatum |
Q46881179 | Motor-skill learning-associated gene regulation in the striatum: effects of cocaine |
Q30585970 | Natural neural projection dynamics underlying social behavior |
Q44512975 | Neurochemical changes in dopamine D1, D3 and D1/D3 receptor knockout mice |
Q48239434 | Neuromodulatory effect of Gαs- or Gαq-coupled G-protein-coupled receptor on NMDA receptor selectively activates the NMDA receptor/Ca2+/calcineurin/cAMP response element-binding protein-regulated transcriptional coactivator 1 pathway to effectively i |
Q42504109 | Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors |
Q44342408 | Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity |
Q44205834 | Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine. |
Q43875632 | Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors. |
Q36205868 | Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. |
Q48654037 | Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo |
Q36211464 | Psychostimulants, madness, memory... and RGS proteins? |
Q36479818 | Region-dependent dynamics of cAMP response element-binding protein phosphorylation in the basal ganglia |
Q46381667 | Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors |
Q52317578 | Restoration of Kv7 Channel-Mediated Inhibition Reduces Cued-Reinstatement of Cocaine Seeking. |
Q22252576 | Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis |
Q33873281 | Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine. |
Q48307475 | Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors |
Q100527193 | Sex-specific behavioral and neurogenic responses to cocaine in mice lacking and blocking dopamine D1 or dopamine D2 receptors |
Q37925513 | Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation. |
Q28551389 | The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats |
Q42461221 | The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice |
Q44722668 | The dopamine D3 receptor and drug addiction |
Q37946259 | The dynorphin/κ-opioid receptor system and its role in psychiatric disorders |
Q35978068 | The opioid receptors as targets for drug abuse medication |
Q34268520 | The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout'). |
Q28348761 | The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice |
Q90950669 | The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses |
Q34420295 | Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems |
Q47823604 | Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach. |
Q51990334 | Using knockout and transgenic mice to study neurophysiology and behavior. |
Q44178896 | Withdrawal duration differentially affects c-fos expression in the medial prefrontal cortex and discrete subregions of the nucleus accumbens in cocaine-sensitized rats |
Q48331506 | c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes. |
Q41191508 | c-Fos is an intracellular regulator of cocaine-induced long-term changes |
Search more.